Treace to Report Third Quarter 2026 Financial Results on November 6, 2026
Key Highlights
- ➤Treace (TMCI) will report third-quarter 2026 financial results before trading begins November 6, 2026
- ➤Management will host an earnings conference call at 8:00 a.m. ET on November 6
- ➤Treace estimates 1.1 million annual surgical candidates among approximately 67 million Americans with bunions
PONTE VEDRA, Fla., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the third quarter 2026 before the start of trading on Friday, November 6, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET.
Investors interested in listening to the conference call may do so by registering. Once registered, participants will receive dial-in numbers and a unique pin to join the call and ask questions. A live and archived webcast of the event will be available on the Company’s investor relations website at https://investors.treace.com/.
Get started
Create a free account to read the full story.